Page last updated: 2024-11-04

chlorpropham

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Chlorpropham: A carbamate that is used as an herbicide and as a plant growth regulator. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

chlorpropham : A carbamate ester that is the isopropyl ester of 3-chlorophenylcarbamic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2728
CHEMBL ID104560
CHEBI ID34630
SCHEMBL ID54464
SCHEMBL ID22437601
MeSH IDM0004206

Synonyms (163)

Synonym
BIDD:ER0253
BRD-K59590127-001-02-9
cipc
elbanil
spud-nie
n-(3-chloor-fenyl)-isopropyl carbamaat
101-21-3
nsc-29466
nsc29466
metoxon
isopropyl 3-chlorophenylcarbamate
preweed
n-(3-chlorophenyl)isopropyl carbamate
isopropyl m-chlorocarbanilate
spud-nic
chloripc
isopropyl n-(3-chlorophenyl)carbamate
n-(3-chlor-phenyl)-isopropyl-carbamat
y 3
chloropropham
wln: gr cmvoy1 & 1
isopropyl n-chlorophenylcarbamate
furloe 3 ec
isopropyl n-(m-chlorophenyl)carbamate
n-(3-chlorophenyl)carbamic acid, isopropyl ester
fasco wy-hoe
preventol 56
ent 18,060
(3-chlorophenyl)carbamic acid, 1-methylethyl ester
chloro-ifk
chloro-ipc
3-chlorocarbanilic acid, isopropyl ester
o-isopropyl n-(3-chlorophenyl)carbamate
liro cipc
nexoval
m-chlorocarbanilic acid isopropyl ester
prevenol 56
taterpex
stopgerme-s
sprout nip
triherbicide cipc
n-(3-chloro phenyl)carbamate d'isopropyle
chlorprophame
isopropyl 3-chlorocarbanilate
ci-ipc
furloe
n-(3-cloro-fenil)-isopropil-carbammato
chlorpropham
DIVK1C_006600
KBIO1_001544
NCI60_002445
isopropyl-n-(3-chlorophenyl) carbamate
1-methylethyl (3-chlorophenyl)carbamate
chlorprophame [french]
einecs 202-925-7
bud nip
mirvale
furloe 3ec
isopropyl meta-chlorocarbanilate
furloe 4ec
chloro ipc
n-(3-chloor-fenyl)-isopropyl carbamaat [dutch]
cl-ifk
isopropyl-m-chlorocarbanilate
isopropyl-n-m-chlorophenyl-carbamate
ci-ifk
chlor ifc
chlorprophame [iso-french]
chlor ifk
chlor-ifc
n-(3-chloro phenyl) carbamate d'isopropyle [french]
chlorpropham [bsi:iso]
m-chlorocarbanilic acid, isopropyl ester
unicrop cipc
keim-stop
n-(3-cloro-fenil)-isopropil-carbammato [italian]
n-(3-chlor-phenyl)-isopropyl-carbamat [german]
chlor ipc
hsdb 981
isopropyl (3-chlorophenyl)carbamate
epa pesticide chemical code 018301
bud-nip
isopropyl-n-(3-chlorophenyl)carbamate
brn 2211397
1-methylethyl(3-chlorophenyl)carbamate
sprout-nip ec
ai3-18060
caswell no. 510a
isopropyl-n-(3-chlorphenyl)-carbamat [german]
isopropyl-n-3-chlorophenyl carbamate
nsc 29466
SPECTRUM_001883
carbamic acid, (3-chlorophenyl)-, 1-methylethyl ester
carbanilic acid, m-chloro-, isopropyl ester
BSPBIO_002423
n-3-chlorophenylisopropylcarbamate
NCGC00094538-03
NCGC00094538-01
NCGC00094538-02
KBIO2_002407
KBIOSS_002413
KBIOGR_001143
KBIO2_007543
KBIO3_001923
KBIO2_004975
SPECPLUS_000504
SPECTRUM4_000682
SPECTRUM3_000842
SPBIO_000167
SPECTRUM2_000044
SPECTRUM330051
SPECTRUM5_002000
NCGC00094538-05
NCGC00094538-04
chlorpropham, ~95%, crystalline
AC-11051
chebi:34630 ,
CHEMBL104560
AKOS003369049
propan-2-yl n-(3-chlorophenyl)carbamate
NCGC00094538-06
NCGC00094538-07
C2555
n-(3-chlorophenyl)carbamic acid isopropyl ester
dtxcid10764
tox21_301139
NCGC00255037-01
cas-101-21-3
dtxsid7020764 ,
tox21_201866
NCGC00259415-01
CCG-39995
ccris 9259
unii-0hbu04r8b0
n-(3-chloro phenyl) carbamate d'isopropyle
isopropyl-n-(3-chlorphenyl)-carbamat
0hbu04r8b0 ,
FT-0631534
chlorpropham [mi]
chlorpropham [hsdb]
1-methylethyl n-(3-chlorophenyl)carbamate
chlorpropham [iso]
SCHEMBL54464
KS-5118
propan-2-yl (3-chlorophenyl)carbamate
isopropyl m-chloro carbanilate
carbamic acid, n-(3-chlorophenyl)-, 1-methylethyl ester
prevenol (salt/mix)
CWJSHJJYOPWUGX-UHFFFAOYSA-N
isopropyl chlorocarbanilate
gro stop (salt/mix)
J-000342
chlorpropham, pestanal(r), analytical standard
chlorpropham 100 microg/ml in acetonitrile
chlorpropham 10 microg/ml in acetonitrile
mfcd00037108
Q904901
D97609
SCHEMBL22437601
HY-W014240
A851706
chlorpropham 100 microg/ml in methanol
CS-W014956

Research Excerpts

Overview

Chlorpropham is a widely used sprouting inhibitor applied on potatoes during their storage. It inhibits cell division and has been widely used as a potato sprout suppressant.

ExcerptReferenceRelevance
"Chlorpropham is a carbamate herbicide that inhibits cell division and has been widely used as a potato sprout suppressant. "( Evaluation of Cellular Uptake and Removal of Chlorpropham in the Treatment of
Harvey, PJ; Mazzucchi, L; Xu, Y, 2022
)
2.42
"Chlorpropham is a widely used sprouting inhibitor applied on potatoes during their storage. "( Fate of Chlorpropham during High-Temperature Processing of Potatoes.
Bücking, M; Göckener, B; Kling, HW; Kotthoff, M, 2020
)
2.44

Toxicity

ExcerptReferenceRelevance
" There were no adverse effects of chlorpropham on either litter size or litter weight and sex ratio at birth."( Reproductive and neurobehavioural toxicity study of chlorpropham in mice.
Tanaka, T, 1999
)
0.83
" Phenisopham was the most toxic in the long term exposure while its five derivatives showed lower chronic potential for rotifers and algae."( Chlorpropham and phenisopham: phototransformation and ecotoxicity of carbamates in the aquatic environment.
Criscuolo, E; DellaGreca, M; Iesce, MR; Isidori, M; Lavorgna, M; Parrella, A; Passananti, M; Temussi, F, 2014
)
1.85

Bioavailability

ExcerptReferenceRelevance
" Pharmacokinetic analysis of the formulation data indicated that the SEDDS formulation provided only marginally better oral bioavailability compared to a suspension formulation."( Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations.
Brenner, T; Jain, PK; Karlage, K; Kuehl, PJ; Mayersohn, M; Myrdal, PB; Sepassi, K; Yalkowsky, SH; Yang, G, 2008
)
0.62

Dosage Studied

ExcerptRelevanceReference
" The first study was conducted to determine administration time, and the second study was designed to evaluate dose-response effects."( Developmental toxicity of chlorpropham in mice.
Fujitani, T; Oishi, S; Takahashi, O; Tanaka, T; Yoneyama, M,
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
herbicideA substance used to destroy plant pests.
plant growth retardantnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency35.48135.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency33.42030.007215.758889.3584AID1224835
15-lipoxygenase, partialHomo sapiens (human)Potency31.62280.012610.691788.5700AID887
pregnane X receptorRattus norvegicus (Norway rat)Potency35.48130.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency16.38120.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency40.72530.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743054; AID743063
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency21.55410.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency61.13060.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency6.23550.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency10.16240.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency39.40090.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.99680.000229.305416,493.5996AID1259383; AID588513; AID743069; AID743075; AID743080; AID743091
aryl hydrocarbon receptorHomo sapiens (human)Potency37.55390.000723.06741,258.9301AID651777; AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency6.24130.001723.839378.1014AID743083
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency45.11050.057821.109761.2679AID1159526; AID1159528
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency12.58930.001815.663839.8107AID894
histone deacetylase 9 isoform 3Homo sapiens (human)Potency13.38010.037617.082361.1927AID1259364; AID1259388
heat shock protein beta-1Homo sapiens (human)Potency60.75590.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency27.30600.000627.21521,122.0200AID720636
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency11.22020.00798.23321,122.0200AID2551
Cellular tumor antigen p53Homo sapiens (human)Potency30.20220.002319.595674.0614AID651631
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency61.44010.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency60.26130.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (141)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (40)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (26)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID679012TP_TRANSPORTER: drug resistance in MRP1-expressing NIH/3T3 cells2003Toxicology letters, Apr-30, Volume: 142, Issue:1-2
The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID112694In vivo anticonvulsant activity determined as icv dose that blocked tonic seizures induced by audiogenic stimuli in DBA/2 mice after pretreatment with D-serine2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID622160Antimicrobial activity against Plasmodium falciparum up to 128 uM2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
Synthesis and evaluation of phosphoramidate and phosphorothioamidate analogues of amiprophos methyl as potential antimalarial agents.
AID112693In vivo anticonvulsant activity determined as icv dose that blocked clonic seizures induced in DBA/2 mice by audiogenic stimuli2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID112692In vivo anticonvulsant activity determined as icv dose that blocked clonic seizures induced by audiogenic stimuli in DBA/2 mice after pretreatment with D-serine2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID112691In vivo anticonvulsant activity determined as icv dose that blocked NMDA-induced tonic seizures induced in DBA/2 mice after ip administration2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID112689In vivo anticonvulsant activity determined as icv dose that blocked 3,5-DHPG induced tonic seizures induced in DBA/2 mice after2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID112688In vivo anticonvulsant activity determined as icv dose that blocked 3,5-DHPG induced clonic seizures induced in DBA/2 mice2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID112695In vivo anticonvulsant activity determined as icv dose that blocked tonic seizures induced in DBA/2 mice by audiogenic stimuli2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID1101850Inhibition of Avena sativa var. Zenshin seed germination assessed as coleoptile length at 1 uM after 6 days (Rvb = 9.5 cm)2002Bioscience, biotechnology, and biochemistry, Feb, Volume: 66, Issue:2
Preparation of N-substituted aryl and alkyl carbamates and their inhibitory effect on oat seed germination.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
AID112690In vivo anticonvulsant activity determined as icv dose that blocked NMDA-induced clonic seizures induced in DBA/2 mice2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
AID1101849Inhibition of Avena sativa var. Zenshin seed germination assessed as root length at 1 uM after 6 days (Rvb = 7 cm)2002Bioscience, biotechnology, and biochemistry, Feb, Volume: 66, Issue:2
Preparation of N-substituted aryl and alkyl carbamates and their inhibitory effect on oat seed germination.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (29.13)18.7374
1990's16 (15.53)18.2507
2000's22 (21.36)29.6817
2010's20 (19.42)24.3611
2020's15 (14.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.32 (24.57)
Research Supply Index4.78 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index62.22 (26.88)
Search Engine Supply Index2.06 (0.95)

This Compound (41.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.54%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other115 (97.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]